Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Robert Radie named president & CEO of TransMolecular

This article was originally published in Scrip

Executive Summary

TransMolecular (US) has appointed Robert Radie president and chief executive officer. Michael Egan, the company's former president and CEO, has been promoted to vice-chairman. Mr Radie, who previously served as a full-time business development consultant for the company, has more than 23 years' experience in the pharmaceutical and biotechnology industry. Before joining TransMolecular, he was executive vice-president and chief business officer at Prestwick Pharmaceuticals, and vice-president of project management and chief business officer at Morphotek.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts